<DOC>
	<DOC>NCT02593149</DOC>
	<brief_summary>To assess blood stream infections in participants using two FDA-cleared devices: ClearGuard HD end caps compared to the Tego® connector with the Curos® for Tego disinfecting port protector.</brief_summary>
	<brief_title>Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap</brief_title>
	<detailed_description>Prospective, cluster-randomized, open-label, post market, comparative effectiveness evaluation with facilities participating for up to 12 months.</detailed_description>
	<mesh_term>Kidney Failure, Chronic</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<criteria>All patients dialyzing with a central venous catheter Known allergy to chlorhexidine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>